OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis

Clinical Cancer Research

Volumn 10, Issue 24, 2004, Pages 8544-8547

  Jones, Timothy D ^a   Ulbright, Thomas M ^a   Eble, John N ^a   Cheng, Liang ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ANTIBODY; BIOLOGICAL MARKER; OCTAMER TRANSCRIPTION FACTOR 4; VIMENTIN;

ARTICLE; ARTIFACT; AUTOPSY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSPLASIA; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; ORCHIECTOMY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SEMINOMA; SENSITIVITY AND SPECIFICITY;

ALKALINE PHOSPHATASE; DNA-BINDING PROTEINS; GERMINOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; ORCHIECTOMY; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 11144247220     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0688     Document Type: Article

References (33)

1. Faulkner S, Leigh D, Oosterhuis J, Roelofs H, Looijenga L, Friedlander M. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer 2000;83:729-36.
2. Looijenga LH, Gillis AJ, Van Putten WL, Oosterhuis JW. In situ numeric analysis of centromeric regions of chromosomes 1, 12, and 15 of seminomas, nonseminomatous germ cell tumors, and carcinoma in situ of human testis. Lab Investig 1993;68:211-9.
3. van Echten J, van Gurp RJ, Stoepker M, Looijenga LH, de Jong J, Oosterhuis W. Cytogenetic evidence that carcinoma in situ is the precursor lesion for invasive testicular germ cell tumors. Cancer Genet Cytogenet 1995;85:133-7.
4. Coffin CM, Ewing S, Dehner LP. Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features. Arch Pathol Lab Med 1985;109:555-9.
5. Skakkebaek NE, Berthelsen JG, Visfeldt J. Clinical aspects of testicular carcinoma-in-situ. Int J Androl 1981;4(suppl):153-62.
6. Giwercman A, von der Maase H, and Skakkebaek NE. Epidemiological and clinical aspects of carcinoma in situ of the testis. In: NE Skakkebaek, KM Grigor, A Giwercman, and M Rørth (eds.), Management and biology of carcinoma in situ and cancer of the testis. Basel: S Krager; 1993. p. 104-14.
7. Krabbe S, Skakkebaek NE, Berthelsen JG, et al. High incidence of undetected neoplasia in maldescended testes. Lancet 1979;1:999-1000.
8. Giwercman A, Bruun E, Frimodt-Moller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989;142:998-1001.
9. Muller J, Skakkebaek NE, Ritzen M, Ploen L, Petersen KE. Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr 1985;106:43t-6.
10. von der Maase H, Rorth M, Walbom-Jorgensen S, et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 1986;293:1398-401.
11. Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod 2000;6:999-1004.
12. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990;60:461-72.
13. Rosner MH, Vigano MA, Ozato K, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature (Lond) 1990;345:686-92.
14. Scholer HR, Dressier GR, Balling R, Rohdewohld H, Gruss P. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J 1990;9:2185-95.
15. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003;63:2244-50.
16. Burke AP, Mostofi FK. Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol 1988;19:663-70.
17. Manivel JC, Jessurun J, Wick MR, Dehner LP. Placental alkaline phosphatase immunoreactivity in testicular germ-cell neoplasms. Am J Surg Pathol 1987;11:21-9.
18. Jacobsen GK, Norgaard-Pedersen B. Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study Acta Pathol Microbiol Immunol Scand [A] 1984;92:323-9.
19. Beckstead JH. Alkaline phosphatase histochemistry in human germ cell neoplasms. Am J Surg Pathol 1983;7:341-9.
20. Koide O, Iwai S, Baba K, Iri H. Identification of testicular atypical germ cells by an immunohistochemical technique for placental alkaline phosphatase. Cancer (Phila) 1987;60:1325-30.
21. Hustin J, Collette J, Franchimont P. Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl 1987;10:29-35.
22. Ulbright TM, Amin MB, Young RH. Tumors of the testis, adnexa, spermatic cord, and scrotum. Washington D.C.: Armed Forces Institute of Pathology, 1999.
23. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for testicular seminoma and embryonal carcinoma. Am J Surg Pathol 2004;28:935-40.
24. Cheng L, Thomas A, Roth LM, Zheng WM, Michael H, Abdul-Karim FW. OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol. 2004;28:1341-6.
25. Cheng L. Establishing germ cell origin for metastatic tumors using OCT4 immunohisotochemitsry. Cancer 2004;101:2006-10.
26. Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987;10:19-28.
27. Pryor JP, Cameron KM, Chilton CP, et al. Carcinoma in situ in testicular biopsies from men presenting with infertility. Br J Urol 1983;55:780-4.
28. Skakkebaek NE. Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 1978;2:157-70.
29. Muller J, Skakkebaek NE. Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome. Br Med J (Clin Res Ed) 1984;288:1419-20.
30. Bottomley D, Fisher C, Hendry WF, Horwich A. Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ cell tumours. Br J Urol 1990;66:420-4.
31. von der Maase H, Meinecke B, Skakkebaek NE. Residual carcinoma-in-situ of contralateral testis after chemotherapy. Lancet 1988;1:477-8.
32. Rajpert-De Meyts E, Kvist M, Skakkebaek NE. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance. Virchows Arch 1996;428:133-9.
33. Rajpert-De Meyts E, Skakkebaek NE. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl 1994;17:85-92.